Peptech
Generated 5/9/2026
Executive Summary
PepTech Corporation is a US-based premium chemistry partner specializing in custom synthesis, specialty amino acids, and medicinal chemistry services for drug discovery. Founded in 1990 and ISO 9001 certified, the company operates R&D and manufacturing facilities in Shanghai and Dalian, China, serving a global customer base. As a critical enabler for pharmaceutical and biotech companies, PepTech provides essential building blocks and chemistry services that accelerate early-stage research through scale-up. The company benefits from the growing demand for peptide-based therapeutics and complex small molecules, positioning it well within the drug development supply chain. While private and without disclosed financials, PepTech's long-standing presence and strategic location in China offer cost advantages and operational reliability. The company's expertise in custom synthesis and medicinal chemistry makes it a key partner for organizations seeking specialized chemical support, driving steady demand and potential for growth.
Upcoming Catalysts (preview)
- 2027Expansion of manufacturing capacity in China70% success
- TBDStrategic partnership with a major pharmaceutical company60% success
- TBDIncrease in outsourcing of peptide synthesis services due to market growth80% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)